NetApp vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 83)

NetApp

LeaderConsumer Technology

Enterprise

San Jose CA intelligent data infrastructure (NASDAQ: NTAP) ~$6.5B FY2025 revenue; ONTAP all-flash arrays + Azure/AWS/GCP cloud storage services, NVIDIA AI pipeline partner competing with Pure Storage and Dell EMC.

AI VisibilityBeta
Overall Score
A83
Category Rank
#284 of 290
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
88
Gemini
80

About

NetApp, Inc. is a San Jose, California-based intelligent data infrastructure company — publicly traded on NASDAQ (NASDAQ: NTAP) as an S&P 500 Information Technology component — providing cloud-led, data-centric storage and data management solutions for enterprises deploying hybrid multi-cloud architectures, AI workloads, and modern application environments through approximately 11,000 employees worldwide. NetApp's product portfolio centers on its ONTAP operating system for all-flash arrays (AFF/ASA product lines), delivering unified storage for block, file, and object workloads — and its cloud storage services: Azure NetApp Files (ANF, native Microsoft Azure integration), Amazon FSx for NetApp ONTAP (AWS native integration), and Cloud Volumes ONTAP for Google Cloud — which collectively enable enterprises to use the same ONTAP data management capabilities on-premises and in all three hyperscale clouds. For fiscal year 2025 (ending April 2025), NetApp reported approximately $6.5 billion in revenue with continued all-flash array growth and cloud storage services expanding at 20%+ annually. CEO George Kurian has led the company since 2015, executing the strategic transformation from on-premises storage vendor to intelligent data infrastructure platform. NetApp's AI data pipeline solutions — purpose-built for NVIDIA DGX and GPUDirect Storage workflows — position the company as infrastructure for enterprise AI training and inference at scale.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

83
Overall Score
90
#284
Category Rank
#9
67
AI Consensus
60
stable
Trend
stable
77
ChatGPT
99
88
Perplexity
99
80
Gemini
83
78
Claude
96
88
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.